Wealth Enhancement Advisory Services, LLC Organogenesis Holdings Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49.5 Billion
- Q4 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 39,159 shares of ORGO stock, worth $176,215. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,159
Previous 34,374
13.92%
Holding current value
$176,215
Previous $109,000
14.68%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ORGO
# of Institutions
123Shares Held
61.8MCall Options Held
4.3KPut Options Held
3.9K-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$56.2 Million2.78% of portfolio
-
Morgan Stanley New York, NY11.8MShares$53.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$22.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$16.2 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.08MShares$13.9 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $589M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...